بدائل البحث:
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
significant decrease » significant increase (توسيع البحث), significantly increased (توسيع البحث)
larger decrease » marked decrease (توسيع البحث)
nn decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), mean decrease (توسيع البحث)
-
301
-
302
-
303
-
304
-
305
-
306
-
307
-
308
Socio-demographic characteristics of women in study sample (means except as noted).
منشور في 2025الموضوعات: -
309
Regression model summary outputs: Skilled delivery with MAMA kit (Binary exposure.).
منشور في 2025الموضوعات: -
310
-
311
Frequencies: Skilled delivery & skilled delivery with MAMA kit by exposure to remittances.
منشور في 2025الموضوعات: -
312
-
313
-
314
Regression model summary outputs: Skilled delivery with MAMA kit (Continuous exposure).
منشور في 2025الموضوعات: -
315
-
316
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
-
317
-
318
-
319
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
منشور في 2025"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
-
320
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
منشور في 2025"…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"